Ojjaara approved in the US as the first and only treatment for myelofibrosis patients with anaemia
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
The hospital hosted a two-day event with top internal and external faculty and medical experts
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
Uses a simple mechanical approach for removing intrauterine tissues
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
Subscribe To Our Newsletter & Stay Updated